Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders - PubMed
Review
Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders
Silvia Rivara et al. Curr Top Med Chem. 2008.
Abstract
Melatonin (N-acetyl-5-methoxytryptamine) is synthesized and released by the pineal gland following a circadian rhythm characterized by high levels during the night. It shows several pharmacological effects on diverse cellular and animal models, mainly related to either its antioxidant activity or to its ability to activate specific receptors (MTr). Melatonin is widely used as a self-administered food additive, but its therapeutic potential needs more investigation and is hampered by its poor pharmacokinetics. This review will focus on the medicinal chemistry of agonist ligands of the two human GPCRs MT(1) and MT(2) melatonin receptors. The recent introduction of ramelteon, a non-selective MT(1)/MT(2) agonist for the treatment of insomnia, and the advancement to clinical trials of other MTr agonists have renewed interest for different classes of compounds endowed with this activity. Several chemical classes of MTr agonists are described in the literature, generally characterized by an indole, or an indole bioisostere, carrying an amide side chain and a methoxy group, or substituents with similar stereoelectronic features. Abundant information is available for non-selective MT(1)/MT(2) ligands, and several molecular models, both ligand- and receptor-based, have been proposed to rationalize their structure activity relationships. Fewer classes of selective agonists have been reported in the literature, and they could help clarifying the physiological role of the two receptor subtypes. A brief discussion on the therapeutic potential of this class of compounds is based on the clinical data available for the agonists ramelteon, agomelatine, beta-methyl-6-chloromelatonin (TIK-301) and VEC-162.
Similar articles
-
Melatonin receptor agonists: new options for insomnia and depression treatment.
Spadoni G, Bedini A, Rivara S, Mor M. Spadoni G, et al. CNS Neurosci Ther. 2011 Dec;17(6):733-41. doi: 10.1111/j.1755-5949.2010.00197.x. CNS Neurosci Ther. 2011. PMID: 21554566 Free PMC article. Review.
-
Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, Cardinali DP. Srinivasan V, et al. Int J Neurosci. 2009;119(6):821-46. doi: 10.1080/00207450802328607. Int J Neurosci. 2009. PMID: 19326288 Review.
-
Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
Pandi-Perumal SR, Srinivasan V, Poeggeler B, Hardeland R, Cardinali DP. Pandi-Perumal SR, et al. Nat Clin Pract Neurol. 2007 Apr;3(4):221-8. doi: 10.1038/ncpneuro0467. Nat Clin Pract Neurol. 2007. PMID: 17410109 Review.
-
Uchiyama M. Uchiyama M. Nihon Rinsho. 2015 Jun;73(6):1017-22. Nihon Rinsho. 2015. PMID: 26065135 Review. Japanese.
-
Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.
Spadoni G, Bedini A, Lucarini S, Mor M, Rivara S. Spadoni G, et al. Expert Opin Drug Metab Toxicol. 2015 Jul;11(7):1145-56. doi: 10.1517/17425255.2015.1045487. Epub 2015 May 8. Expert Opin Drug Metab Toxicol. 2015. PMID: 25956235 Review.
Cited by
-
Hardeland R. Hardeland R. Aging Dis. 2012 Apr;3(2):194-225. Epub 2011 Feb 10. Aging Dis. 2012. PMID: 22724080 Free PMC article.
-
Synthetic melatoninergic ligands: achievements and prospects.
Kostiuk NV, Belyakova MB, Leshchenko DV, Zhigulina VV, Miniaev MV. Kostiuk NV, et al. ISRN Biochem. 2014 Feb 23;2014:843478. doi: 10.1155/2014/843478. eCollection 2014. ISRN Biochem. 2014. PMID: 25937968 Free PMC article. Review.
-
Oprea-Ilies G, Haus E, Sackett-Lundeen L, Liu Y, McLendon L, Busch R, Adams A, Cohen C. Oprea-Ilies G, et al. Breast Cancer Res Treat. 2013 Feb;137(3):677-87. doi: 10.1007/s10549-012-2371-3. Epub 2012 Dec 19. Breast Cancer Res Treat. 2013. PMID: 23250547 Free PMC article.
-
Structural insights into melatonin receptors.
Stauch B, Johansson LC, Cherezov V. Stauch B, et al. FEBS J. 2020 Apr;287(8):1496-1510. doi: 10.1111/febs.15128. Epub 2019 Nov 23. FEBS J. 2020. PMID: 31693784 Free PMC article. Review.
-
Hu Y, Chan KH, He X, Ho MK, Wong YH. Hu Y, et al. PLoS One. 2014 Dec 5;9(12):e113638. doi: 10.1371/journal.pone.0113638. eCollection 2014. PLoS One. 2014. PMID: 25479338 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous